EUVIMEDEUVIMED entdecken
Vergleichsstudie

Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE

Chloé Buchalet, Claire Lemanski, Pascal Pommier, Karine Le Malicot, Nathalie Bonichon-Lamichhane, Ludovic Evesque, Olivia Diaz, Philippe Ronchin, Laurent Quero, Eleonor Rivin Del Campo, David Tougeron, Sandrine Salas und 3 weitere

Digestive and Liver Disease · 2025

DOI: 10.1016/j.dld.2024.06.022 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Chloé Buchalet und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. Electronic address: chloe.buchalet@icm.unicancer.fr. Hauptthemen laut MEDLINE: Anus Neoplasms, Chemoradiotherapy, Carcinoma, Squamous Cell, Propensity Score. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Early-stage anal squamous cell carcinomas (ASCC) are usually treated with chemoradiotherapy (CRT), with good outcomes. Radiotherapy (RT) alone might be sufficient while reducing toxicity. METHODS: Patients included in the French prospective FFCD-ANABASE and treated for T1-2N0 ASCC between 2015/01 and 2020/04 were divided into CRT and RT groups. Clinical outcomes and toxicity were reported. Propensity score matching was conducted for 105 pairs of patients. RESULTS: 440 patients were analyzed: 261 (59.3 %) in the CRT group and 179 (40.7 %) in the RT group. The median follow-up was 35.7 months. Patients receiving CRT were younger, had better Performance Status (PS) and larger tumors. No statistical difference was observed for 3-year Disease-free survival (85.3 % vs 83 %, p = 0.28), Overall survival (89.6 % vs 94.8 %, p = 0.69) and Colostomy-free survival (84.5 % vs 87.2 %, p = 0.84) between CRT and RT groups, respectively. Propensity score-matched analysis confirmed these findings. Treatment interruptions were significantly more frequent in the CRT group (36.3 % vs 21.9 %, p = 0.0013), resulting in an Overall Treatment Time (OTT) extended by 7 days. Grade 3 CTCAE v4.0 toxicities were more prevalent in the CRT group (46 % vs 19 %, p < 0.001). CONCLUSION: Adding chemotherapy to radiotherapy did not significantly improve outcomes for T1-2N0 ASCC in our study, but increased toxicity and OTT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anus NeoplasmsChemoradiotherapyCarcinoma, Squamous CellPropensity ScoreHumansFemaleMaleMiddle AgedAgedFranceProspective StudiesNeoplasm StagingDisease-Free SurvivalAdultAged, 80 and over

Stichwörter der Autor:innen

Anal cancerChemoradiotherapyEarly stageToxicity

Autor:innen und Institutionen

  • Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. Electronic address: chloe.buchalet@icm.unicancer.fr.
  • Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France.
  • Department of Radiation Oncology, Institut Curie, Paris, France.
  • Fédération Francophone de Cancérologie Digestive, University of Burgundy, Dijon, France.
  • Radiotherapy, Tivoli Clinic, Bordeaux, France.
  • Department of Radiation Oncology, Antoine Lacassagne Cancer Center, Nice, France.

Zitieren

APA

Buchalet, C., Lemanski, C., Pommier, P., Le Malicot, K., Bonichon-Lamichhane, N., Evesque, L., Diaz, O., Ronchin, P., Quero, L., Campo, E. R. D., Tougeron, D., Salas, S., Bengrine-Lefevre, L., Lepage, C., & Vendrely, V. (2025). Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.06.022

Vancouver

Buchalet C, Lemanski C, Pommier P, Le Malicot K, Bonichon-Lamichhane N, Evesque L, et al. Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.06.022

BibTeX
@article{Buchalet2025,
  author = {Buchalet, Chloé and Lemanski, Claire and Pommier, Pascal and Le Malicot, Karine and Bonichon-Lamichhane, Nathalie and Evesque, Ludovic and Diaz, Olivia and Ronchin, Philippe and Quero, Laurent and Campo, Eleonor Rivin Del and Tougeron, David and Salas, Sandrine and Bengrine-Lefevre, Leila and Lepage, Côme and Vendrely, Véronique},
  title = {Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE},
  journal = {Digestive and Liver Disease},
  year = {2025},
  doi = {10.1016/j.dld.2024.06.022}
}
Kostenlos starten →